Himly Martin, Carnés Jerónimo, Fernández-Caldas Enrique, Briza Peter, Ferreira Fatima
Abt. für Molekulare Biologie, Universität Salzburg.
Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess. 2009;96:61-9; discussion 69-70.
So far it has not been possible to measure the amount of major allergens in the complexes after chemical modification. Furthermore, the presence of minor allergens remained obscure, unless antibodies were successfully generated by animal immunization with allergoids and shown to be reactive with purified natural or recombinant allergens in immunological assays. Thus, we adapted and employed a set of physicochemical methods with the aim of elucidating the molecular size and allergen composition of allergoids. Using online-HPSEC light scattering and DLS, it was shown that two thirds of depigmented allergoid prepared from birch pollen extracts adopted a MW between 1000 and 2000 kDa. The question of reproducibility of the polymerization reaction was addressed by investigating four batches of P. pratense allergoid. Three out of the four batches contained 73 to 77% of polymerized molecules in the above-mentioned range of molecular sizes. One batch showed a significantly higher content of molecules with a MW exceeding 2 MDa. Analysis of allergen composition in B. alba allergoids revealed the presence of all relevant Bet v 1 isoforms and minor allergens except for Bet v 3 and Bet v 4, which was in good agreement with the allergens detected in the native extracts. It should be noted that Bet v 3 has not been detected at the protein level before. Similarly, good agreement in allergen composition between allergoid and native extract was also found for D. pteronyssinus. Presently, the European Directorate for Quality of Medicines and Healthcare (EDQM) is committed to the application of the 3R principles (i. e. replace, reduce, refine the use of animals) for the quality control of medicines wherever possible. This is reflected by the regular review of the monographs of the European Pharmacopoeia and the introduction of alternative tests. For instance, recently it was decided to replace the rabbit pyrogen test by an in vitro test. Furthermore, through the Biological Standardisation Programme the EDQM develops, validates, and establishes alternative test methods in the field of quality control of biologicals (personal communication with Karl-Heinz Buchheit, EDQM). Therefore, the approach presented here for the characterization of allergoids relying on physicochemical methods shall also serve the growing needs for alternative methods to animal testing.
到目前为止,还无法测量化学修饰后复合物中主要过敏原的含量。此外,除非通过用变应原类毒素对动物进行免疫成功产生抗体,并在免疫分析中证明其与纯化的天然或重组过敏原具有反应性,否则次要过敏原的存在仍不清楚。因此,我们采用并运用了一套物理化学方法,旨在阐明变应原类毒素的分子大小和过敏原组成。使用在线高效尺寸排阻色谱光散射法和动态光散射法表明,从桦树花粉提取物制备的三分之二的脱色变应原类毒素的分子量在1000至2000 kDa之间。通过研究四批车前草变应原类毒素,探讨了聚合反应的可重复性问题。四批中的三批含有73%至77%的上述分子大小范围内的聚合分子。一批显示分子量超过2 MDa的分子含量明显更高。对白桦变应原类毒素中过敏原组成的分析表明,除了Bet v 3和Bet v 4外,所有相关的Bet v 1亚型和次要过敏原均存在,这与在天然提取物中检测到的过敏原高度一致。应当指出,此前尚未在蛋白质水平检测到Bet v 3。同样,在屋尘螨变应原类毒素和天然提取物之间的过敏原组成方面也发现了良好的一致性。目前,欧洲药品和医疗保健质量管理局(EDQM)致力于尽可能在药品质量控制中应用3R原则(即替代、减少、优化动物使用)。这体现在定期审查欧洲药典各论以及引入替代试验中。例如,最近决定用体外试验取代兔热源试验。此外,通过生物标准化计划,EDQM在生物制品质量控制领域开发、验证并建立替代试验方法(与EDQM的Karl-Heinz Buchheit的个人交流)。因此,这里提出的依靠物理化学方法表征变应原类毒素的方法也应满足对替代动物试验方法日益增长的需求。